Search research articles
Contact Us
Filters
Showing results (201-210 of 266) with videos related to
Page
of 27
Sort By:
Cancer Research
|
July 9, 2017
Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells
Lucia Borriello, Rie Nakata, Michael A Sheard, et al.
Journal for Immunotherapy of Cancer
|
January 11, 2021
Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice
Michael John Zobel, Abigail K Zamora, Hong-Wei Wu, et al.
Cancer Gene Therapy
|
September 1, 1995
Sustained cytokine production and immunophenotypic changes in human neuroblastoma cell lines transduced with a human gamma interferon vector
K Uçar, R C Seeger, P M Challita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2010
Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study
Wendy B London, Christopher N Frantz, Laura A Campbell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2007
De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene
Naohiko Ikegaki, Takahiro Gotoh, Bing Kung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2009
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study
Katherine K Matthay, C Patrick Reynolds, Robert C Seeger, et al.
International Journal of Cancer
|
April 18, 2018
Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes
Matthew W Webb, Jianping Sun, Michael A Sheard, et al.
Cancer Research
|
March 3, 2006
The MYCN enigma: significance of MYCN expression in neuroblastoma
Xao X Tang, Huaqing Zhao, Bing Kung, et al.
The Journal of Clinical Investigation
|
May 5, 2009
Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
Liping Song, Shahab Asgharzadeh, Jill Salo, et al.
The Journal of Clinical Investigation
|
August 22, 2007
Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma
Liping Song, Tasnim Ara, Hong-Wei Wu, et al.
Page
of 27
Search research articles
Search
Showing results (201-210 of 266) with videos related to
Sort By:
Page
of 27
Cancer Research
|
July 9, 2017
Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells
Lucia Borriello, Rie Nakata, Michael A Sheard, et al.
Journal for Immunotherapy of Cancer
|
January 11, 2021
Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice
Michael John Zobel, Abigail K Zamora, Hong-Wei Wu, et al.
Cancer Gene Therapy
|
September 1, 1995
Sustained cytokine production and immunophenotypic changes in human neuroblastoma cell lines transduced with a human gamma interferon vector
K Uçar, R C Seeger, P M Challita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2010
Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study
Wendy B London, Christopher N Frantz, Laura A Campbell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2007
De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene
Naohiko Ikegaki, Takahiro Gotoh, Bing Kung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2009
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study
Katherine K Matthay, C Patrick Reynolds, Robert C Seeger, et al.
International Journal of Cancer
|
April 18, 2018
Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes
Matthew W Webb, Jianping Sun, Michael A Sheard, et al.
Cancer Research
|
March 3, 2006
The MYCN enigma: significance of MYCN expression in neuroblastoma
Xao X Tang, Huaqing Zhao, Bing Kung, et al.
The Journal of Clinical Investigation
|
May 5, 2009
Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
Liping Song, Shahab Asgharzadeh, Jill Salo, et al.
The Journal of Clinical Investigation
|
August 22, 2007
Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma
Liping Song, Tasnim Ara, Hong-Wei Wu, et al.
Page
of 27